Proteasome inhibitor enhances growth hormone-binding protein release.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2001-09-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0303-7207(01)00583-4PMID 11514050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteasomes are involved in the constitutive degradation of growth hormone receptors.

  2001cited by this paper
• Activation-dependent degradation of protein kinase Cη

  2000cited by this paper
• Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation.

  2000cited by this paper
• Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent*

  2000cited by this paper
• Activation of Atypical Protein Kinase C ζ by Caspase Processing and Degradation by the Ubiquitin-Proteasome System*

  2000cited by this paper
• Activation-dependent degradation of protein kinase C eta.

  2000cited by this paper
• Dynamic re‐distribution of protein kinase D (PKD) as revealed by a GFP‐PKD fusion protein: dissociation from PKD activation

  1999cited by this paper
• Role of ecto-kinase in phorbol ester-enhanced growth hormone-binding protein release from human IM-9 cells.

  1999cited by this paper
• Generation of chicken growth hormone-binding proteins by proteolysis.

  1999cited by this paper
• Structure and expression of the mouse growth hormone receptor/growth hormone binding protein gene.

  1999cited by this paper
• New insights into the regulation of protein kinase C and novel phorbol ester receptors

  1999cited by this paper
• The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.

  1998cited by this paper
• Activation of protein kinase Cα enhances human growth hormone-binding protein release

  1998cited by this paper
• Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation

  1998cited by this paper
• Activation of protein kinase C alpha enhances human growth hormone-binding protein release.

  1998cited by this paper
• The serum growth hormone binding protein: pregnant with possibilities.

  1997cited by this paper
• Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes

  1996cited by this paper
• Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes.

  1996cited by this paper
• Ubiquitination of protein kinase C-alpha and degradation by the proteasome.

  1996cited by this paper
• Ubiquitination of Protein Kinase C-α and Degradation by the Proteasome*

  1996cited by this paper
• Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin

  1996cited by this paper
• Release of a soluble form of growth hormone receptors (growth hormone-binding proteins) from human IM-9 cells by proteolytic cleavage.

  1995cited by this paper
• Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor.

  1995cited by this paper
• Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling.

  1995cited by this paper
• The Hep G2 cell line in the study of growth hormone receptor/binding protein.

  1994cited by this paper
• Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

  1993cited by this paper
• Evidence for generation of the growth hormone-binding protein through proteolysis of the growth hormone membrane receptor.

  1993cited by this paper
• Human growth hormone-stimulated growth of human cultured lymphocytes (IM-9) and its inhibition by phorbol diesters through down-regulation of the hormone receptors. Possible involvement of phosphorylation of a 55,000 molecular weight protein associated with the receptor in the down-regulation.

  1990cited by this paper
• Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains.

  1989cited by this paper
• The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor.

  1989cited by this paper
• Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies.

  1989cited by this paper
• Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation.

  1988cited by this paper
• Growth hormone receptor and serum binding protein: purification, cloning and expression

  1987cited by this paper
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Tumor Necrosis Factor- � Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and

  year unknowncited by this paper

• Comprehensive Review On Graphene Oxide For Use In Drug Delivery System.

  2019cites this paper
• Food Shortage Causes Differential Effects on Body Composition and Tissue-Specific Gene Expression in Salmon Modified for Increased Growth Hormone Production

  2015cites this paper
• Proteasome inhibition activates the transport and the ectodomain shedding of TNF-α receptors in human endothelial cells

  2005influential citation
• Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage.

  2005cites this paper
• Growth Hormone Receptor Is a Target for Presenilin-dependent γ-Secretase Cleavage*

  2005cites this paper
• Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum.

  2003cites this paper
• A method to increase the number of growth hormone receptors at the surface of cells.

  2003cites this paper